Pharmaceutical - Pharmaceutical, Women's Health

Filter

Popular Filters

1 to 25 of 84 results

Aeterna Zentaris and Ascend Therapeutics team up to market each other's products

Aeterna Zentaris and Ascend Therapeutics team up to market each other's products

05-08-2014

Quebec-based biopharma drug developer Aeterna Zentaris has said it is to collaborate with women’s healthcare…

AEterna ZentarisAscend PharmaClinical researchDavid DoddEstroGelHealthcare specialistMarkets & MarketingPharmaceuticalPharmaceutical sciencesUSAWomen's Health

Levonorgestrel and ulipristal remain suitable emergency contraceptives, says EMA

24-07-2014

The European Medicines Agency has concluded its review of emergency contraceptives containing levonorgestrel…

EuropeLevonorgestrelNorLevoPharmaceuticalRegulationReproductiveulipristalWomen's Health

Highlights of EMA Pharmacovigilance committee July meeting

Highlights of EMA Pharmacovigilance committee July meeting

14-07-2014

The European Medicines Agency's Pharmacovigilance Risk Assessment Committee (PRAC) concluded two safety…

bromocriptineEuropeNephrology and HepatologyNeurologicalPharmaceuticalRegulationRiensoTakeda Pharmaceuticalvalproate Sodium InjectionWomen's Health

EMA/CHMP positive opinion for Teva’s Seasonique contraceptive

EMA/CHMP positive opinion for Teva’s Seasonique contraceptive

04-07-2014

The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive…

EuropePharmaceuticalRegulationReproductiveSeasoniqueTeva Pharmaceutical IndustriesWomen's Health

Ferring and Roche collaborate to develop personalized infertility treatment

Ferring and Roche collaborate to develop personalized infertility treatment

25-06-2014

Privately-held Switzerland-headquartered Ferring Pharmaceuticals and Swiss drug major Roche have entered…

Ferring PharmaceuticalsPharmaceuticalReproductiveResearchRocheWomen's Health

US orphan status for EffRx’ EX404 for pediatric polycystic ovary syndrome

US orphan status for EffRx’ EX404 for pediatric polycystic ovary syndrome

11-06-2014

Swiss drug delivery specialist EffRx Pharmaceuticals says the US Food and Drug Administration has granted…

EffRx PharmaceuticalsEX404metforminPharmaceuticalRare diseasesRegulationUSAWomen's Health

Richter and HRA Pharma in deal on Esmya for Latin America

30-05-2014

Hungary’s largest drugmaker Gedeon Richter and France-based Laboratoire HRA Pharma have concluded a…

EsmyaGedeon RichterHRA PharmaLicensingPharmaceuticalSouth AmericaWomen's Health

GPs lack awareness of NICE guidelines on HMB, survey shows

GPs lack awareness of NICE guidelines on HMB, survey shows

09-05-2014

Less than 5% of UK general practitioners (GPs) prescribe in line with guidelines from the National Institute…

BayerHealth Medical PharmaHealth Medical PharmaMilitary scienceNavigationPharmaceuticalRegulationSocial IssuesUKWomen's Health

Merck, Ferring and WHO working together to prevent excessive bleeding in women after childbirth

Merck, Ferring and WHO working together to prevent excessive bleeding in women after childbirth

06-04-2014

US pharma giant Merck & Co and privately-held Switzerland-headquartered Ferring Pharmaceuticals have…

carbetocinFerring PharmaceuticalsGlobalMarkets & MarketingMerck & CoPharmaceuticalResearchWomen's Health

GSK withdraws European marketing authorization for ovarian cancer drug Votrient

GSK withdraws European marketing authorization for ovarian cancer drug Votrient

31-03-2014

UK pharma major GlaxoSmithKline has withdrawn its application to the European Medicines Agency for a…

GlaxoSmithKlineOncologyPharmaceuticalRegulationUKVotrientWomen's Health

US FDA approves NDA from Actavis and Valeant

US FDA approves NDA from Actavis and Valeant

26-03-2014

US generics major Actavis and Canada’s Valeant Pharmaceuticals said that the US Food and Drug Administration…

ActavisCanadaGenericsMetronidazolePharmaceuticalRegulationUSAValeant PharmaceuticalsWomen's Health

Mike Sullivan appointed president of Avion Pharmaceuticals

Mike Sullivan appointed president of Avion Pharmaceuticals

18-03-2014

Avion Pharmaceuticals, a US-based specialty pharmaceutical company, has announced the promotion of Mike…

Avion PharmaceuticalsBoardroomNovartisPharmaceuticalReproductiveSanofiTher-RxUSAWomen's Health

Dilafor partners with Lee’s Pharmaceutical for tafoxiparin

24-02-2014

Sweden-based Dilafor AB, a Karolinska Development portfolio company, and Lee’s Pharmaceutical Holdings,…

Asia-PacificChinaDilafor ABKarolinska DevelopmentLee's PharmaceuticalLicensingPharmaceuticalReproductivetafoxiparinWomen's Health

Sprout Pharmaceuticals to resubmit NDA for flibanserin

Sprout Pharmaceuticals to resubmit NDA for flibanserin

12-02-2014

US privately-held sexual health specialists Sprout Pharmaceuticals has received ‘clear guidance’…

flibanserinPharmaceuticalRegulationSprout PharmaceuticalsUSAWomen's Health

European Commission approves Gedeon Richter’s Esmya type II Variation

European Commission approves Gedeon Richter’s Esmya type II Variation

27-01-2014

The European Commission has granted marketing authorization to extend the use of Esmya (ulipristal acetate)…

EsmyaEuropeGedeon RichterPharmaceuticalRegulationWomen's Health

Advaxis out-licenses ADXS-HPV to Biocon for emerging markets

Advaxis out-licenses ADXS-HPV to Biocon for emerging markets

23-01-2014

Indian biotech firm Biocon has entered into an exclusive licensing agreement for US cancer drug developer…

AdvaxisADXS-HPVAsia-PacificBioconIndiaLicensingOncologyPharmaceuticalWomen's Health

EMA pharmacovigilance unit calls for suspension of Protelos/Osseor

EMA pharmacovigilance unit calls for suspension of Protelos/Osseor

10-01-2014

The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC) has recommended…

Anti-Arthritics/RheumaticsEuropeOsseorPharmaceuticalProtelosRegulationServierWomen's Health

Everett Labs acquires Quinnova Pharma to diversify US market presence

27-12-2013

US specialty pharma firm Everett Laboratories, a subsidiary of Spain’s Exeltis, has acquired Quinnova…

Amneal EnterprisesDermatologicalsEverett LaboratoriesExeltisMergers & AcquisitionsNorth AmericaPharmaceuticalQuinnova PharmaceuticalsUSAWomen's Health

Two Latin America acquisitions for Gedeon Richter

23-12-2013

In what was a busy couple of days for Hungary’s largest drugmaker Gedeon Richter, the company announced…

BrazilGedeon RichterMergers & AcquisitionsNext PharmaPharmaceuticalSouth AmericaWomen's Health

Torrent to acquire Indian branded formulations from Elder

13-12-2013

Torrent Pharmaceuticals saw its shares rise 7% to 349 rupees after it said it is acquiring the branded…

Asia-PacificElder PharmaceuticalsIndiaMergers & AcquisitionsNeurologicalPharmaceuticalTorrent PharmaceuticalsWomen's Health

Retrophin to acquire Kyalin Biosciences; in-licenses Syntocinon

13-12-2013

In a second takeover bid within a matter of months, USA-based Retrophin announced that it will acquire…

Kyalin BiosciencesLicensingMergers & AcquisitionsNeurologicalNorth AmericaNovartisPharmaceuticalRetrophinSyntocinonWomen's Health

No increase in risk of autism from taking SSRIs in pregnancy

25-11-2013

New research cannot establish a close connection between the use of antidepressant medication - the so-called…

NeurologicalPharmaceuticalResearchWomen's Health

Benefits of combined hormonal contraceptives continue to outweigh risks, says EMA/CHMP

Benefits of combined hormonal contraceptives continue to outweigh risks, says EMA/CHMP

23-11-2013

The European Medicines Agency has now completed its review of combined hormonal contraceptives (CHCs),…

EuropePharmaceuticalRegulationReproductiveWomen's Health

Merck’s new HPV vaccine could rejuvenate market, says GlobalData

Merck’s new HPV vaccine could rejuvenate market, says GlobalData

18-11-2013

Despite being hampered both by apathy and resistance in recent years, the human papillomavirus (HPV)…

CervarixGardasilGlaxoSmithKlineMarkets & MarketingMerck & CoPharmaceuticalV503VaccinesWomen's Health

1 to 25 of 84 results

Back to top